BIOMAT Database Logo BIOMAT Database Logo

New broad-spectrum cephalosporins with anti-pseudomonal activity. III. Synthesis and antibacterial activity of 7 beta-[D-2-(4-hydroxy-6-methylpyridine-3-carbonylamino)-2-(4-hydroxyphenyl) acetamido]-3-(methyl or substituted methyl)-ceph-3-em-4-carboxylic acids. 1983

H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome

The influence of various 3-substituents on the antibacterial activity of 7 beta-[D-2-(4-hydroxy-6-methylpyridine-3-carbonylamino)-2-(4-hydroxyphenyl) acetamido]ceph-3-em-4-carboxylic acids (III) was investigated. Introduction of an acidic substituent, such as a sulfo or a carboxyl group, to a 3-(1-methyl-1H-tetrazolyl)thiomethyl substituent (IIIf--i) resulted in a marked loss of activity against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis, Escherichia coli, Klebsiella pneumoniae, and Enterobacter aerogenes, in contrast to an in crease of activity against Proteus mirabilis. Displacement of the acetoxy group of IIIb with pyridines (IIIm--p) enhanced the activity against P. aeruginosa and E. aerogenes: their activity against those strains were superior to that of the cephalosporin IIId having a 3-(1-methyl-1H-tetrazolyl)thiomethyl substituent. As a result of extensive studies in addition to the study of in vitro activity in this series, 7 beta-[D-2-(4-hydroxy-6-methylpyridine-3-carbonylamino)-2-(4-hydroxyphenyl) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]ceph-3-em-4-carboxylic acid, code No. SM-1652, cefpiramide (generic name), was selected as a candidate for further biological and clinical investigations.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Semisynthetic cephalosporins. III. Synthesis and structure activity relationships of novel orally active 7-[4-hydroxy-3-(substituted methyl)phenyl]-acetamido-3-cephem-4-carboxylic acids.
January 1980, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
[Synthesis of 7 beta-(6-substituted-2-quinolone-3-acetamido)cephalosporins].
January 1989, Yao xue xue bao = Acta pharmaceutica Sinica,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Studies on cephalosporin antibiotics. I. Synthesis, antibacterial activity and oral absorption of new 3-(O-substituted)-7 beta-[D-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]cephalosporins.
February 1988, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
[New beta-lactam antibiotics. Derivatives of 3-hydroxy-7-amino-ceph-3-em-4-carboxylic acid].
November 1974, Helvetica chimica acta,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Semisynthetic cephalosporins. IV. Synthesis and structure activity relationships of parenterally active 7-[4-(substituted methyl)phenyl]-acetamido-3-cephem-4-carboxylic acids.
October 1981, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Semisynthetic beta-lactam antibiotics. III. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-(substituted carbamoylmethoxyimino)acetamido]cephalosporins.
September 1986, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
[Studies on beta-lactam antibiotics for medicinal purpose. XVII. Synthesis and structure-activity relationships of 7 beta-[D(-)-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]-3-substituted methyl-3-cephem-4-carboxylic acids].
February 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Studies on cephalosporin antibiotics. III. Synthesis, antibacterial activity and oral absorption of new 3-(substituted-alkylthio)-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2- (carboxymethoxyimino)acetamido]cephalosporins.
May 1991, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
[Synthetic cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]-3-(1,2,3-triazol-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds].
December 1989, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Yamada, and H Tobiki, and K Jimpo, and T Komatsu, and T Okuda, and H Noguchi, and T Nakagome
Synthesis of 7-thio-substituted 4-oxoquinoline-3-carboxylic acids with antibacterial activity.
August 1990, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!